Prime editing deal flurry to nail down patent rights
By Carrie Arnold,
Nature Biotechnology
| 04. 17. 2024
Tome Biosciences came out of stealth mode on 12 December with a haul of over $200 million to develop the company’s gene editing platform. Tome’s first order of business was to snap up Replace Therapeutics to expand its toolkit to one equipped to make gene edits in DNA sequences big and small.
Tome’s own genomic technology, mediated by an integrase, is well suited to large DNA up to tens of thousands of kilobases long. Replace’s CRISPR–Cas9 ligase-mediated platform, by contrast, is adept at inserting and deleting small DNA sequences of 10–100 base pairs. Having both of these technologies in its pocket, says Tome CEO Rahul Kakkar, means that the company can potentially replace an entire gene with a wild-type version rather than correct a defective version, and without requiring double-stranded breaks in DNA.
The merger, worth $65 million up front and potentially up to $185 million total for Replace, is one of the largest acquisitions in the booming prime editing field. Although Kakkar says that the acquisition was driven not by patent coverage but to expand Tome’s gene editing toolkit...
Related Articles
By Fyodor Urnov, Time | 08.12.2024
After a lifetime in the field of epigenetics, and nearly 20 years after my colleagues and I coined the term “genome editing,” I will be the first to admit that describing the “epigenome”—a marvelous biological process that guides...
By Azeen Ghorayshi and Sarah Kliff, The New York Times | 08.12.2024
An emerging movement against in vitro fertilization is driving some doctors and patients in red states to move or destroy frozen embryos.
The embryo migration is most striking in Alabama, where the State Supreme Court ruled in February that embryos...
By Gemma Conroy, Nature | 06.27.2024
Image by Robina Weermeijer from Unsplash
A molecular-editing tool that’s small enough to be delivered to the brain shuts down the production of proteins that cause prion diseases, a rare but deadly group of neurodegenerative disorders.
The system — known...
By Staff, AP-NORC | 07.12.2024
Image by Dr. Jayesh Amin from Wikimedia Commons licensed under CC by-SA 3.0
Most adults support protecting access to in vitro fertilization, or IVF, a type of fertility treatment where eggs are combined with sperm outside the body in a...